Safety and efficacy of a modified busulfan/cyclophosphamide conditioning regimen incorporating cladribine for autologous hematopoietic stem cell transplantation in acute myeloid leukemia

• Autors principals: Yuan-Yuan Shi (Autor), Zeng-Yan Liu (Autor), Gui-Xin Zhang (Autor), Yi He (Autor), Ming-Zhe Han (Autor), Si-Zhou Feng (Autor), Rong-Li Zhang (Autor), Er-Lie Jiang (Autor)
• Format: Llibre
• Publicat: Frontiers Media S.A., 2023-02-01T00:00:00Z.
• Matèries: article
• Accés en línia: Connect to this object online.

This is a small phase I study examining the safety and efficacy of a cladribine (CLAD)-containing conditioning regimen prior to autologous hematopoietic stem cell transplantion (auto-HSCT) for patients with acute myeloid leukemia (AML). All patients, aged 15-54 years (median 32 years), had favorable...